Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
NCT ID: NCT06230887
Last Updated: 2025-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
200 participants
INTERVENTIONAL
2024-07-30
2028-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Veterans managing MIS have difficulty responding to mental health treatment, and are at increased risk for suicide ideation or attempts. To date evidence-based interventions for MIS are not widely available in VA. This study will implement an evidence-based intervention for MIS in four VA facilities, collect data on the effectiveness of the intervention, and develop an implementation toolkit. This data will inform national dissemination in collaboration with the Office of Mental Health and Suicide Prevention and the National Chaplain Service.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thriving in the Midst of Moral Pain: The Acceptability and Feasibility of Acceptance and Commitment Therapy for Moral Injury (ACT-MI) Among Warzone Veterans
NCT03760731
Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD
NCT03681288
A Randomized Controlled Trial of a Web-Based Moral Elevation Intervention for Veterans With PTSD
NCT06788678
Pilot Study Testing a Web-Based Moral Elevation Intervention for Veterans With PTSD and Moral Injury
NCT03906240
Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure
NCT03056157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This clinical trial will be one of the first to measure symptoms of MIS as a primary outcome. Hypotheses are:
1. Compared to Present Centered Group Therapy (PCGT), BSS will significantly decrease symptoms of MIS.
2. Compared to PCGT, BSS will significantly decrease symptoms of PTSD, depression, and suicidal ideation.
Significance: To date there are not standard procedures for assessing and treating MIS, so it is likely that untreated MIS is contributing to poor outcomes, including suicides. Developing an implementation toolkit so that BSS is widely available in VA facilities could reduce the impact of MIS on Veterans' mental health.
Innovation and Impact: To date there have not been funded implementation studies on treatments for MIS in Veterans, and very few VA facilities provide evidence-based care for MIS. This study can clear the way to make evidence-based care for MIS more accessible in the VA system.
Specific Aims:
1. Conduct a mixed methods pre-implementation evaluation to identify barriers and facilitators for BSS implementation at each site, and to develop local implementation strategies. Specific implementation variables assessed, based on the Proctor and EBQI models include acceptability, appropriateness, and feasibility. Specific variables to be assessed will include a) acceptability of BSS to stakeholders, b) available implementation resources, and c) organizational openness to adding a new EBP.
2. Conduct a randomized controlled trial comparing BSS to Present Centered Group Therapy (PCGT) for Veterans who score above cutoff on the Moral Injury Outcomes Scale. Effectiveness and functional outcomes will be informed by the psychospiritual developmental model of MIS.
3. Conduct a mixed methods post-implementation evaluation to compare outcomes across chaplaincy managed vs. mental health managed BSS programs. Proctor model outcomes will include adoption, fidelity, penetration, and sustainability. Specific outcomes related to this framework include a) successful BSS implementation, b) fidelity in implementation of BSS, c) percentage of eligible, referred Veterans who access BSS services, and d) qualitative reports of intent to maintain the BSS program when the study is complete.
Methodology: This will be a type 2 hybrid study, combining pre- and post-implementation evaluations with a randomized clinical trial at 4 culturally diverse VA sites.
Next Steps and Implementation: Data on barriers and facilitators will be used to develop a toolkit and collaborate with study partners at the Office of Mental Health and Suicide Prevention and the National Chaplain Service to develop a national dissemination plan for BSS. The investigators will work with existing clinical staffing at the study sites, so that those sites can continue to provide BSS services after the study. Furthermore, after completing this study, BSS leaders will be qualified to train BSS leaders at other sites, creating resources for training and national dissemination.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Building Spiritual Strength
Spiritually integrated group intervention for moral injury.
Building Spiritual Strength
Spiritually Integrated group intervention for moral injury
Present Centered Group Therapy
Coping strategies group intervention addressing broad spectrum trauma symptoms
Present Centered Group Therapy
Active control, manualized evidence-based coping skills intervention for PTSD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Building Spiritual Strength
Spiritually Integrated group intervention for moral injury
Present Centered Group Therapy
Active control, manualized evidence-based coping skills intervention for PTSD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (a) validation of any of the first three items on the Moral Injury and Distress Scale, which is consistent with probable MIS
* (b) willingness to be randomized to either treatment condition
* (c) stability on mental health medications for at least 8 weeks
* (d) age of 18 years or older
Exclusion Criteria
* (b) active psychosis or substance use at levels that would interfere with treatment, assessed via chart review, the Alcohol Use Disorders Identification Test - Concise (AUDIT-C) score, and the Mini International Neuropsychiatric Interview (MINI)
* (c) currently involved in evidence-based psychotherapy for MIS, or evidence-based psychotherapy for PTSD, assessed via chart review and intake interview
* (d) managing any severe psychopathology that, in the opinion of the investigative team, requires immediate clinical attention, such as imminent suicide risk, assessed via the MINI and supplemental homicide risk questions.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Central Alabama Health Care System
UNKNOWN
VA Atlanta Healthcare System
UNKNOWN
Michael E. DeBakey VA Medical Center
FED
Minneapolis Veterans Affairs Medical Center
FED
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeanette Irene Harris, PhD MS MS
Role: PRINCIPAL_INVESTIGATOR
Maine VA Medical Center, Augusta, ME
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Arkansas Veterans Healthcare System , Little Rock, AR
Little Rock, Arkansas, United States
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, United States
Maine VA Medical Center, Augusta, ME
Augusta, Maine, United States
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, United States
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIR 22-132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.